Hepatitis B & C Update: New Zealand Resident Visa Health Rules 2026

For years, a hepatitis B or hepatitis C diagnosis was one of the quiet reasons people hesitated to apply for a New Zealand Resident Visa. Not because they weren't otherwise eligible, but because they'd heard, correctly, that the health requirement could be an automatic dead end.

That's no longer the default outcome.

From 3 August 2026, Immigration New Zealand (INZ) has removed hepatitis B and hepatitis C from its list of high-cost health conditions used to assess New Zealand Resident Visa applications. In practical terms, having either condition will no longer, on its own, trigger a finding that you don't meet the "acceptable standard of health" requirement.

If you've been putting off your NZ Resident Visa application because of a hepatitis diagnosis, held either your own or a family member's, this is worth understanding properly before you assume anything about your chances.

Why Immigration New Zealand Changed This Rule

New Zealand's immigration health requirements aren't just about whether a condition is treatable. They're built around cost. INZ assesses whether a health condition is likely to impose "significant costs" on New Zealand's health or disability services, using a fixed threshold currently set at NZD $81,000 over the relevant assessment period.

Historically, hepatitis B and hepatitis C sat on INZ's high-cost conditions list, meaning an applicant with either diagnosis was, in most cases, automatically assessed as failing the acceptable standard of health, regardless of how well-managed their condition actually was.

That assumption is now out of date. Treatment for both conditions has improved substantially over the past decade. Antiviral therapies for hepatitis B are more affordable and effective than they once were, and direct-acting antivirals have turned hepatitis C from a chronic, hard-to-manage illness into something that's frequently curable with a defined course of treatment. The expected cost of managing either condition now sits comfortably below the $81,000 threshold for most people.

INZ developed this change in consultation with the Ministry of Health, and Pharmac has also indicated support for removing both conditions from the high-cost list.

What Actually Changes for Your New Zealand Resident Visa Application

It's worth being precise here, because this change doesn't mean hepatitis B or C is no longer relevant to your health assessment. It means the automatic fail is gone.

Before 3 August 2026: Automatic Fail for NZ Resident Visa Applicants

An applicant with hepatitis B or hepatitis C was generally assessed as not meeting the acceptable standard of health by default, because the condition itself sat on the high-cost list.

From 3 August 2026: Individual Assessment for Your New Zealand Resident Visa

Hepatitis B and hepatitis C are assessed on an individualised basis, like most other medical conditions. A panel physician or medical assessor looks at your actual clinical picture, not a blanket assumption tied to the diagnosis.

This is a meaningful shift from a rule-based exclusion to a case-by-case judgment. It doesn't guarantee a pass. It means your specific circumstances, viral load, liver function, treatment history, and current management, are what gets assessed, rather than the diagnosis alone closing the door.

Who This Affects

This change applies to NZ Resident Visa applications submitted on or after 3 August 2026. It's relevant to anyone applying for residence who has, or has previously had, hepatitis B or hepatitis C, including:

• Skilled Migrant Category (SMC) applicants

• Green List and Work to Residence applicants

• Partnership and family category applicants

• Dependent children included in a residence application

Visa Categories Where This New Zealand Resident Visa Rule Applies

It's also relevant if a family member included in your application, rather than you personally, has the condition. Health assessments under most residence categories apply to everyone included in the application, not just the primary applicant.

If you already hold a temporary visa and aren't applying for residence, this change doesn't apply to you in the same way. Temporary visa health requirements are assessed differently, and hepatitis status is generally less likely to be an issue for shorter-term visas in the first place.

What Hasn't Changed

A few things are worth being clear-eyed about for your New Zealand Resident Visa application, because this is a genuinely positive update, but it isn't a blanket exemption.

You still need a medical examination. Panel physician requirements haven't gone away. If your visa category requires a medical certificate, you'll still complete one, and hepatitis B or C will still appear in your results if present.

Other conditions can still trigger the high-cost threshold. If you have hepatitis B or C alongside another condition, or complications like cirrhosis or liver cancer, the overall clinical picture is what gets assessed. A well-managed, early-stage hepatitis B diagnosis is a very different assessment from advanced liver disease.

Character and other requirements still apply. Health is one requirement among several. Meeting the health standard doesn't affect character, English language, or the substantive visa criteria for your chosen pathway.

This is a policy update, not legislation. INZ has stated the decision reflects current treatment costs and clinical evidence. Policy settings like this can, in principle, be revisited if circumstances change, though there's no indication that's imminent.

Also read: Permanent Resident Visa Made Easy with Licensed Immigration Advisers NZ

Why This Matters Beyond the Policy Detail

For a lot of families, particularly those from regions where hepatitis B is more prevalent due to historical vaccination gaps or perinatal transmission, this diagnosis has carried a disproportionate weight in immigration planning. People have delayed applications, sought unnecessary workarounds, or assumed residence simply wasn't realistic, based on outdated information or a rule that no longer reflects the actual cost of treatment.

If that's been sitting in the back of your mind, either for yourself or a family member on your application, it's worth getting a proper, current assessment rather than relying on advice or assumptions from a few years ago. Immigration health policy has moved. Your plans might need to move with it.

What You Should Do Before You Apply for Your New Zealand Resident Visa

1. Don't assume an old rejection still applies. If you were previously advised against applying because of a hepatitis diagnosis, that advice may now be outdated. It's worth revisiting.

2. Get your medical documentation in order early. Recent liver function results, viral load testing, and specialist letters showing your condition is monitored or well-managed will support a stronger individualised assessment.

3. Check which category you're applying under. Health assessment processes differ slightly between residence categories, so confirm the requirements for your specific pathway before booking a panel physician appointment.

4. Get a professional opinion before you submit. An individualised assessment still involves judgment calls. Understanding how your specific medical evidence is likely to be read by INZ, before you apply, is far easier than responding to a Potentially Prejudicial Information (PPI) letter after the fact.

Originally published at https://iclegal.co.nz.